Recombinant Gloeobacter violaceus Deoxyribose-phosphate aldolase (deoC)

Shipped with Ice Packs
In Stock

Description

Genomic Context and Evolutionary Significance

Genomic FeatureObservationSource
Genome Size4,659,019 bp (single circular chromosome)
Gene Count4,430 potential protein-coding genes
Photosynthetic GenesMissing psaI, psaJ, psaK, psaX for PSI; poorly conserved psbO, psbU, psbV for PSII

Biochemical Properties of DERA in Bacterial Systems

DERA catalyzes the reversible aldol cleavage of deoxyribose-5-phosphate (DRP) into glyceraldehyde-3-phosphate (G3P) and acetaldehyde. While G. violaceus DERA has not been experimentally characterized, its homologs in other bacteria (e.g., E. coli, Thermus thermophilus) exhibit conserved structural and mechanistic features .

Key Mechanistic Features of DERA

  • Mechanism: Class I aldolase via Schiff base formation with Lys167 and stabilization by Lys201 .

  • Substrate Specificity: Stereospecific for D-glyceraldehyde-3-phosphate; accepts alternative aldehydes (e.g., acetone) .

  • Oligomerization: Typically homodimeric or tetrameric for thermal stability .

ParameterValue (E. coli DERA)Inferred for G. violaceus
Optimal pH7.5–8.0Likely neutral
Temperature StabilityUp to 65°CModerate (mesophilic)
Turnover Number (kcat)0.0029–2.65 s⁻¹Hypothetical, similar range

Hypothesized Role in G. violaceus Metabolism

The deo operon enables bacteria to salvage deoxyribonucleosides, generating G3P (glycolysis) and acetyl-CoA (TCA cycle) . In G. violaceus, which lacks glycolytic enzymes like phosphofructokinase , DERA may play a niche role in:

  1. Nucleotide Recycling: Salvaging deoxyribonucleosides for DNA repair.

  2. Redox Balance: Producing acetaldehyde as a redox cofactor.

Recombinant Expression Challenges

Recombinant production of rGvDERA in heterologous systems (e.g., E. coli) may face hurdles due to:

  • Low Solubility: Observed in other cyanobacterial enzymes (e.g., RuBisCO) .

  • Chaperone Dependency: Potential need for RbcX-like chaperones for proper folding .

Comparison of RuBisCO and DERA Expression

FactorRuBisCO (G. violaceus)Hypothetical DERA
Solubility in E. coliInsoluble (requires RbcX)Likely insoluble
Activity Post-Purification0.0196 μmol min⁻¹ mg⁻¹Unstudied
Chaperone RequirementRbcX for holoenzyme assemblyUnknown

Research Gaps and Future Directions

  1. Functional Characterization: Kinetic assays (e.g., kcat, KM) remain unreported.

  2. Structural Insights: X-ray crystallography to validate TIM barrel fold .

  3. Ecological Relevance: Links to DNA repair or stress response in G. violaceus.

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference for your preparation.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. Please specify your desired tag type for preferential development.
Synonyms
deoC; gll3538Deoxyribose-phosphate aldolase; DERA; EC 4.1.2.4; 2-deoxy-D-ribose 5-phosphate aldolase; Phosphodeoxyriboaldolase; Deoxyriboaldolase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-226
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Gloeobacter violaceus (strain PCC 7421)
Target Names
deoC
Target Protein Sequence
MISSHPEIEL AGFIEQTCLK PTATADDVRQ MCWEAQRYRF AAVCVAPVYA PLAVELLHKQ KPQVFTVVGF PLGLATAPCK LFEAQEAAAR GVTGLEVMVN LGAIKSGHYN AIYEELGQIV DAVGCEVRAI LELNLLDATE RRHVAEVCLD VGVTALKTSA GWSGPVRPED ILGLRRILRN QLGIKVAGGI HTLNQALELL AAGANRLGTG RGVEILREQH ALGKTA
Uniprot No.

Target Background

Function
This recombinant Gloeobacter violaceus Deoxyribose-phosphate aldolase (deoC) catalyzes a reversible aldol reaction between acetaldehyde and D-glyceraldehyde 3-phosphate, yielding 2-deoxy-D-ribose 5-phosphate.
Database Links

KEGG: gvi:gll3538

STRING: 251221.gll3538

Protein Families
DeoC/FbaB aldolase family, DeoC type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is the basic mechanism of action for G. violaceus DERA?

G. violaceus Deoxyribose-phosphate aldolase (DERA) functions as a Class I aldolase, catalyzing the reversible aldol cleavage of deoxyribose-5-phosphate (DRP) into glyceraldehyde-3-phosphate (G3P) and acetaldehyde. The mechanism involves Schiff base formation with a conserved lysine residue (Lys167) and stabilization by another lysine residue (Lys201). This catalytic mechanism allows the enzyme to facilitate carbon-carbon bond formation and cleavage, which is essential for nucleotide metabolism in the organism.

How does G. violaceus DERA compare structurally with other bacterial DERA homologs?

While G. violaceus DERA has not been experimentally characterized in detail, comparative analysis with homologs from other bacteria such as E. coli and Thermus thermophilus suggests it shares conserved structural and mechanistic features. The enzyme likely maintains the core alpha/beta barrel fold characteristic of Class I aldolases, with conserved catalytic residues positioned similarly to those in related organisms. The enzyme typically exists as a homodimer or tetramer, which contributes to its thermal stability and functional properties under physiological conditions.

What biochemical parameters are predicted for G. violaceus DERA based on homologous enzymes?

Based on data from E. coli DERA and other homologs, the following biochemical parameters can be inferred for G. violaceus DERA:

ParameterValue (E. coli DERA)Inferred for G. violaceus
Optimal pH7.5–8.0Likely neutral
Temperature StabilityUp to 65°CModerate (mesophilic)
Turnover Number (kcat)0.0029–2.65 s−1Hypothetical, similar range

These parameters suggest G. violaceus DERA likely functions optimally under neutral pH conditions with moderate temperature stability consistent with the organism's mesophilic nature.

What expression systems are recommended for producing recombinant G. violaceus DERA?

For recombinant production of G. violaceus DERA, E. coli-based expression systems are typically employed, though they may face specific challenges. When designing expression systems, researchers should consider:

  • Codon optimization for the host organism to improve translation efficiency

  • Fusion tags (such as His-tag or MBP) to facilitate purification and potentially enhance solubility

  • Expression temperature optimization (often lower temperatures of 16-25°C improve folding)

  • Co-expression with molecular chaperones that may be necessary for proper folding

Particular attention should be paid to potential solubility issues, as observed with other cyanobacterial enzymes expressed in E. coli. The choice between cytoplasmic expression and periplasmic targeting should be evaluated based on preliminary experiments testing protein activity and solubility.

What purification strategies should be considered for recombinant G. violaceus DERA?

Purification of recombinant G. violaceus DERA requires careful consideration of the enzyme's properties. A multi-step purification strategy is recommended:

  • Initial capture using affinity chromatography (if tagged versions are used)

  • Intermediate purification using ion exchange chromatography

  • Polishing step using size exclusion chromatography to separate oligomeric forms

During purification, researchers should maintain buffer conditions that preserve enzyme stability, typically including:

  • pH between 7.0-8.0

  • Addition of reducing agents (e.g., DTT or β-mercaptoethanol) to prevent oxidation of cysteine residues

  • Glycerol (10-20%) to enhance stability during storage

  • Consideration of specific metal ion requirements

Particular attention should be paid to potential solubility challenges and chaperone dependency, which have been observed with other cyanobacterial enzymes from G. violaceus.

How might the absence of conventional glycolytic enzymes in G. violaceus affect DERA's metabolic role?

G. violaceus lacks conventional glycolytic enzymes such as phosphofructokinase, suggesting alternative metabolic pathways for carbon processing. In this unique metabolic context, DERA may serve specialized functions beyond the typical nucleoside salvage pathway seen in other bacteria. The enzyme likely plays a crucial role in:

  • Nucleotide recycling: Salvaging deoxyribonucleosides for DNA repair and maintenance in an organism with unusual metabolic architecture

  • Redox balance: Producing acetaldehyde as a potential redox cofactor in metabolic pathways that compensate for missing glycolytic enzymes

  • Alternative carbon flux: Channeling deoxyribose-derived carbon into modified central carbon metabolism pathways

Researchers investigating DERA's role should consider designing metabolic flux experiments using labeled substrates to track carbon flow through these alternative pathways, particularly focusing on connections between nucleotide metabolism and central carbon metabolism in this evolutionary distinct cyanobacterium.

What experimental approaches can address the predicted solubility issues with recombinant G. violaceus DERA?

Based on observations with other cyanobacterial enzymes from G. violaceus (such as RuBisCO), recombinant DERA may face solubility challenges in heterologous expression systems. Researchers should consider implementing:

ApproachMethodologyExpected Outcome
Chaperone co-expressionCo-transform with plasmids encoding chaperones (e.g., GroEL/ES, DnaK/J)Enhanced folding and solubility
Fusion partner screeningTest multiple fusion tags (MBP, SUMO, TrxA)Identification of optimal solubility-enhancing tag
Refolding protocolsInclusion body isolation followed by controlled refoldingRecovery of active protein from insoluble fraction
Native source purificationDirect purification from G. violaceus culturesPreservation of natural folding and modifications

Given the potential parallels with RuBisCO expression challenges, researchers should consider whether specific chaperones like RbcX might be required for proper DERA folding and assembly. Comparative analysis with the following data provides insight into potential expression challenges:

FactorRuBisCO (G. violaceus)Hypothetical DERA
Solubility in E. coliInsoluble (requires RbcX)Likely insoluble
Activity Post-Purification0.0196 μmol min−1 mg−1Unstudied
Chaperone RequirementRbcX for holoenzyme assemblyUnknown

How can researchers investigate substrate specificity of G. violaceus DERA for biotechnological applications?

To thoroughly characterize the substrate specificity of G. violaceus DERA, researchers should implement a systematic approach:

  • Establish a reliable activity assay system (spectrophotometric coupled assay or direct product detection)

  • Screen a panel of potential aldehyde acceptors beyond the natural substrate

  • Investigate structure-activity relationships through site-directed mutagenesis of key catalytic residues

  • Perform kinetic analysis (Km, kcat, kcat/Km) with various substrate combinations

  • Utilize computational modeling to predict substrate binding and catalytic efficiency

The enzyme's stereospecificity for D-glyceraldehyde-3-phosphate and its ability to accept alternative aldehydes (such as acetone) provides starting points for this investigation. Researchers should focus on how the unique evolutionary position of G. violaceus might have influenced DERA's substrate preferences compared to homologs from other bacterial sources.

What insights does G. violaceus DERA provide about the evolution of nucleotide metabolism in primitive cyanobacteria?

G. violaceus represents an evolutionary primordial cyanobacterium that branched off from the main cyanobacterial lineage at an early stage of evolution . Its DERA enzyme provides a unique window into early nucleotide metabolism evolution. Several aspects warrant investigation:

  • Phylogenetic analysis comparing G. violaceus DERA to homologs across diverse bacterial lineages

  • Examination of selective pressures on nucleotide salvage pathway genes in primitive photosynthetic organisms

  • Comparison of substrate specificity profiles between G. violaceus DERA and homologs from evolutionarily distant bacteria

The study of G. violaceus DERA should be framed within the context of this organism's unique characteristics, including its lack of thylakoid membranes and photosynthesis occurring in cytoplasmic membranes similar to anoxygenic photosynthetic bacteria . This evolutionary context may explain functional or structural adaptations in DERA that differ from other cyanobacterial homologs.

How does G. violaceus' unusual genomic profile influence interpretations of DERA function?

G. violaceus possesses distinctive genomic features that may influence DERA function and research approaches:

Genomic FeatureObservationPotential Impact on DERA Research
Genome Size4,659,019 bp (single circular chromosome)Potentially simplified metabolic context
Gene Count4,430 potential protein-coding genesFewer redundant pathways or isozymes
Photosynthetic GenesMissing several PSI and PSII componentsUnique metabolic dependencies affecting nucleotide demand

The absence of certain photosynthetic genes (psaI, psaJ, psaK, psaX for PSI; poorly conserved psbO, psbU, psbV for PSII) indicates G. violaceus has a distinctive metabolic architecture. Researchers should consider how these genomic differences might influence nucleotide metabolism demands and consequently DERA's physiological role compared to other cyanobacteria with conventional photosynthetic machinery.

What spectroscopic methods are most suitable for studying G. violaceus DERA catalytic mechanism?

For detailed investigation of G. violaceus DERA's catalytic mechanism, researchers should employ multiple complementary spectroscopic approaches:

  • Stopped-flow spectroscopy to capture transient intermediates during the reaction

  • Circular dichroism (CD) to monitor conformational changes upon substrate binding

  • Fourier-transform infrared spectroscopy (FTIR) to identify vibrational signatures of active site residues

  • Nuclear magnetic resonance (NMR) for studying enzyme-substrate interactions and dynamics

  • UV-visible spectroscopy to monitor Schiff base formation through characteristic absorbance changes

These methods should focus particularly on monitoring the formation and breakdown of the Schiff base intermediate with Lys167, as well as the role of Lys201 in stabilizing transition states. Isotopic labeling strategies (13C, 15N) can enhance the information obtained from these spectroscopic approaches.

What crystallization approaches might overcome challenges in determining G. violaceus DERA structure?

Obtaining high-resolution structural data for G. violaceus DERA may present challenges similar to those encountered with other cyanobacterial enzymes. Researchers should consider:

  • Screening multiple constructs with various truncations or surface mutations to enhance crystallizability

  • Testing co-crystallization with substrates, substrate analogs, or inhibitors to stabilize specific conformations

  • Employing nanobody or antibody fragment co-crystallization to provide additional crystal contacts

  • Exploring crystallization of enzymatically inactive mutants that may adopt more stable conformations

  • Considering alternative structural determination methods such as cryo-electron microscopy if crystallization proves challenging

The high-resolution (2.04 Å) structure determination of G. violaceus PSI by cryo-electron microscopy suggests this approach may be viable for DERA as well, particularly if oligomeric states complicate crystallization efforts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.